ivermectin

News

Despite limited data, anti-parasitic drug ivermectin has become widely used in some areas of the world as a treatment for COVID-19.

News

Novartis has secured EU approval for Itvisma, a new formulation of its spinal muscular atrophy gene therapy usable in a broader patient population.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.